In Brief: Urologix T3
This article was originally published in The Gray Sheet
Executive Summary
Urologix T3: Premarket approval application for targeted transurethral thermo-ablation system is accepted for filing by FDA, Urologix states. The PMA for the device, intended for treatment of benign prostatic hyperplasia without the use of anesthesia, was submitted in March ("The Gray Sheet" March 17, In Brief). FDA has indicated to Urologix that the T3 will not be referred to an FDA advisory panel for review...
You may also be interested in...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.